Worldwide Clinical Trial Imaging Industry to 2027 – Integration of AI to Minimize Errors and Maximize Efficiency Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Imaging Market Research Report by Product & Service, by Modality, by Therapeutic area, by End-User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Clinical Trial Imaging Market size was estimated at USD 908.96 million in 2020, is expected to reach USD 968.95 million in 2021, and is projected to grow at a CAGR of 6.96% to reach USD 1,456.34 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Imaging Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Imaging Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Imaging Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Trial Imaging Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Imaging Market?

6. What is the market share of the leading vendors in the Global Clinical Trial Imaging Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Imaging Market?

Market Dynamics

Drivers

• Significant investments made in drug development programs
• Significant reduction in the drug development and approval timelines
• A non-invasive method of study and usability when a biopsy is not possible

Restraints

• Data security and privacy issues and possibility of misusing the images obtained for studies

Opportunities

• Development of cloud-based platform simplifying the process of image sharing
• Integration of artificial intelligence (AI) to minimize errors and maximize efficiency

Challenges

• High cost associated with the imaging techniques and potential exposure to prohibitive radiation

Companies Mentioned

• anagram 4 clinical trials
• BioClinica Inc.
• Biomedical Systems Corporation
• Biospective Inc.
• BioTelemetry Inc.
• Boston Imaging Core Lab LLC.
• Calyx Group
• Cardiovascular Imaging Technologies LLC.
• ICON plc.
• Imaging Endpoints LI, LLC
• Intrinsic Imaging LLC.
• IXICO plc.
• Lyscaut Medical Imaging Company
• Medical Metrics Inc.
• Medpace Holdings, Inc.
• Micron Inc.
• Parexel International Corporation
• Perspectum Ltd.
• Pharmtrace klinische Entwicklung GmbH
• Prism Clinical Imaging, Inc.
• ProScan Imaging LLC.
• Radiant Sage LLC.
• Resonance Health Ltd.
• WorldCare Clinical, LLC

For more information about this report visit https://www.researchandmarkets.com/r/o5u57a

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900